About the symposium

Resistance to therapy poses a major problem for the successful treatment of cancer, and there is a vast wealth of information emerging in the field of drug resistance to cancer. Today, newly-designed molecular therapies such as immunotherapy, together with improved clinical models and high-throughput screens, are providing an unprecedented understanding of how cancer cells evolve to resist treatment. This exciting and rapidly advancing field therefore demands an opportunity to gather and share key biological advances, as well as to provide a platform for discussion and scientific collaboration, building a path from basic science to translational medicine.

Cell Press is pleased to announce this symposium to discuss the mechanisms by which cancer cells resist therapy, examine ways to overcome resistance, and improve approaches to achieving personalized therapies. Leading experts will present experimental findings from preclinical and clinical studies and place a spotlight on key outstanding questions.

Our online platform will allow you to:

• Easily navigate the program and live-stream sessions and presentations
• Upload your poster presentation and network and chat with attendees
• Engage live with other attendees and speakers through chats, polls, virtual networking meetings and more
• Invite attendees to one-on-one meetings using an integrated appointment schedule
• Access the event via any device - mobile, tablets or desktop
• Access all content of the conference on-demand for 6 months